Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
2.820
-0.080 (-2.76%)
At close: Mar 25, 2026, 4:00 PM EDT
2.850
+0.030 (1.06%)
Pre-market: Mar 26, 2026, 5:33 AM EDT

Achieve Life Sciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
20.9312.7515.5524.7743.02
Short-Term Investments
15.4821.61---
Cash & Short-Term Investments
36.434.3615.5524.7743.02
Cash Growth
5.95%121.02%-37.24%-42.42%20.00%
Other Receivables
--0.110.110.15
Total Trade Receivables
--0.110.110.15
Other Current Assets
3.492.111.332.451.42
Total Current Assets
39.8936.4716.9827.3344.59
Net Property, Plant & Equipment
0.060.120.070.120.06
Other Intangible Assets
0.750.971.21.421.64
Goodwill
1.031.031.031.031.03
Other Long-Term Assets
0.050.040.090.070.18
Total Assets
41.7938.6319.3729.9747.52
Accounts Payable
0.871.950.621.660.84
Accrued Expenses
2.894.682.943.813.64
Current Portion of Long-Term Debt
3.770.0616.7316.130.07
Other Current Liabilities
1.56-0.53--
Total Current Liabilities
9.086.6820.8121.64.55
Long-Term Debt
11.199.840.010.0714.92
Other Long-Term Liabilities
-1.15---
Total Long-Term Liabilities
11.1910.990.010.0714.92
Total Liabilities
20.2717.7320.8221.6719.47
Common Stock
0.120.10.090.090.08
Additional Paid-in Capital
281.61226.34164.21144.15121.55
Accumulated Other Comprehensive Income
0.010.03000
Retained Earnings
-260.23-205.58-165.75-135.94-93.59
Shareholders' Equity
21.5220.9-1.458.328.04
Total Liabilities & Equity
41.7938.6319.3729.9747.52
Total Debt
14.959.8916.7316.214.99
Net Cash (Debt)
21.4524.47-1.198.5728.03
Net Cash Growth
-12.32%---69.41%-21.45%
Net Cash Per Share
0.490.76-0.060.813.45
Book Value
21.5220.9-1.458.328.04
Book Value Per Share
0.490.65-0.070.783.45
Tangible Book Value
19.7318.89-3.685.8525.37
Tangible Book Value Per Share
0.450.59-0.190.553.12
Updated Mar 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q